Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.13 Mil
% of Total Estimate Gain
22.22%

The Gabelli Global Growth Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, The Gabelli Global Growth Fund held - shares of Novo Nordisk AS(NVO), totaling N/A. This investment constitutes 0% of their stock portfolio, and The Gabelli Global Growth Fund now holds 0% of the outstanding Novo Nordisk AS(NVO) stock.

The initial trade took place in 2020Q2. And since then The Gabelli Global Growth Fund has made 4 purchases of NVO, at an average price of $57.24, for a total of 89,200.00 shares. In addition, there have been 4 sales at an average price of $69.96 for 89,200.00 shares. Based on historical transaction data and NVO's current price of $70.73, The Gabelli Global Growth Fund's estimated gain on his NVO holdings is $1.13 Mil, reflecting a 22.22% gain to date.

The Gabelli Global Growth Fund NVO ($70.73) Holding Chart

The Gabelli Global Growth Fund NVO ($70.73) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1